Form CORRESP - Correspondence:
SEC Accession No. 0001641172-25-022236
Filing Date
2025-08-05
Accepted
2025-08-05 16:05:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10443
2 GRAPHIC corresp_001.jpg GRAPHIC 10594
  Complete submission text file 0001641172-25-022236.txt   26243
Mailing Address 2200 N. COMMERCE PARKWAY SUITE 208 WESTON FL 33326
Business Address 2200 N. COMMERCE PARKWAY SUITE 208 WESTON FL 33326 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)